Trials / Active Not Recruiting
Active Not RecruitingNCT04982393
BONAPH1DE, A Prospective Observational Study of Patients With Primary Hyperoxaluria Type 1 (PH1)
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 207 (actual)
- Sponsor
- Alnylam Pharmaceuticals · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to describe the natural history and progression of patients diagnosed with PH1, and to characterize the long-term real-world safety and effectiveness of lumasiran.
Conditions
Timeline
- Start date
- 2021-12-13
- Primary completion
- 2028-09-01
- Completion
- 2028-09-01
- First posted
- 2021-07-29
- Last updated
- 2026-03-31
Locations
30 sites across 11 countries: United States, Belgium, Canada, France, Germany, Israel, Italy, Netherlands, Spain, Switzerland, United Kingdom
Source: ClinicalTrials.gov record NCT04982393. Inclusion in this directory is not an endorsement.